Sage Journals: Discover world-class research

Free access

Review article

First published 2011-11

Impact of HCV Protease-Inhibitor-Based Triple Therapy for Chronic HCV Genotype 1 Infection

Peter Ferenci, K Rajender Reddy

Antiviral Therapy

Free access

Research article

First published 2011-10

NS3 Protease Polymorphism and Natural Resistance to Protease Inhibitors in French Patients Infected with HCV Genotypes 1–5

the ANRS AC11 HCV Group, Sophie Vallet, Florent Viron [...]

Antiviral Therapy

Free access

Research article

First published 2002-04

A Collaborative Screening Program for the Discovery of Inhibitors of HCV NS2/3 cis-Cleaving Protease Activity

Mike Whitney, Jeffrey H. Stack, Paul L. Darke [...]

Journal of Biomolecular Screening

Free access

Research article

First published 2011-7

Impact of Ribavirin on HCV Replicon RNA Decline during Treatment with Interferon-α and the Protease Inhibitors Boceprevir or Telaprevir

Wolf Peter Hofmann, Tje Lin Chung, Carola Osbahr [...]

Antiviral Therapy

Open access

Research article

First published 2022-1

Synthesis and Evaluation of Acylated Derivatives of Hederagenin as Inhibitors of HIV-1 and HCV NS3/4A Proteases

Qing Liu, Ying Wei, Yongjia Hao [...]

Natural Product Communications

Free access

Case report

First published 2013-5

A Boceprevir Failure in a Patient Infected with HCV Genotype 1G: Importance and Limitations of Virus Genotyping Prior to HCV Protease-Inhibitor-Based Therapy

Valeria Cento, Simona Landonio, Francesca De Luca [...]

Antiviral Therapy

Free access

Research article

First published 2017-7

Preclinical Characterization of the Novel HCV NS3 Protease Inhibitor GS-9256

Huiling Yang, Chris Yang, Yujin Wang [...]

Antiviral Therapy

Free access

Research article

First published 2010-8

Structure–activity relationships of HCV NS3 protease inhibitors evaluated on the drug-resistant variants A156T and D168V

Pernilla Örtqvist, Aparna Vema, Angelica E Ehrenberg [...]

Antiviral Therapy

Free access

Research article

First published 2012-11

Rapid and Sharp Decline in HCV upon Monotherapy with Ns3 Protease Inhibitor,Ach-1625

Atul Agarwal, Bao Zhang, Elizabeth Olek [...]

Antiviral Therapy

Retricted access

Research article

First published 2016-05

Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy

Enass A. Abdel-hameed, Susan D. Rouster, Hong Ji [...]

Viral Immunology

Search results